John Spencer

Dr. John Spencer

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2013 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
JSJohn Spencer
John Spencer
ASAndrew L. Schwaderer
Andrew L. Schwaderer
BBBrian Becknell
Brian Becknell
JWJoshua Watson
Joshua Watson
DHDavid S. Hains
David S. Hains

2 October 2017 in Paediatrics and International Child Health
Verified
Journal Article
Closed access
LKLindsey Korbel
Lindsey Korbel
MHMarianella Howell
Marianella Howell
JSJohn Spencer
John Spencer
Urinary tract infections (UTI) are one of the most common and serious bacterial infections encountered by paediatricians and primary care physicians. Although the diagnosis and management of UTI appear simplistic, they remain among the most contentious issues in paediatrics. In part, UTI controversies stem from the absence of classic clinical symptoms, inappropriate urine specimen collection, modified urinary tract imaging recommendations, and diverse treatment and prevention strategies. Recently published guidelines and large clinical trials have attempted to clarify UTI diagnostic and management strategies. In this manuscript, we review the diagnosis and management of acute and recurrent UTI in the paediatric and adolescent populations.

25 November 2014 in Expert Review of Anti-infective Therapy
Verified
Journal Article
Closed access
BBBrian Becknell
Brian Becknell
MSMegan Schober
Megan Schober
LKLindsey Korbel
Lindsey Korbel
JSJohn Spencer
John Spencer
Urinary tract infection (UTI) is one of the most common bacterial infections encountered by pediatricians. Currently, the diagnosis and management of acute UTI and recurrent UTI in children remain ...

1 March 2015 in Journal of Diabetes and its Complications
Verified
Journal Article
Closed access
LKLindsey Korbel
Lindsey Korbel
JSJohn Spencer
John Spencer

1 January 2015 in Kidney International
Verified
Journal Article
Open access
PDF file
BBBrian Becknell
Brian Becknell
TETad E. Eichler
Tad E. Eichler
SBSusana Beceiro
Susana Beceiro
BLBirong Li
Birong Li
RERobert S. Easterling
Robert S. Easterling
JSJohn Spencer
John Spencer
Recent evidence suggests antimicrobial peptides protect the urinary tract from infection. Ribonuclease 7 (RNase 7), a member of the RNase A superfamily, is a potent epithelial-derived protein that maintains human urinary tract sterility. RNase 7 expression is restricted to primates, limiting evaluation of its antimicrobial activity in vivo. Here we identified ribonuclease 6 (RNase 6) as the RNase A superfamily member present in humans and mice that is most conserved at the amino acid level relative to RNase 7. Like RNase 7, recombinant human and murine RNase 6 has potent antimicrobial activity against uropathogens. Quantitative real-time PCR and immunoblot analysis indicate that RNase 6 mRNA and protein are upregulated in the human and murine urinary tract during infection. Immunostaining located RNase 6 to resident and infiltrating monocytes, macrophages, and neutrophils. Uropathogenic E. coli induces RNase 6 peptide expression in human CD14+ monocytes and murine bone marrow–derived macrophages. Thus, RNase 6 is an inducible, myeloid-derived protein with markedly different expression from the epithelial-derived RNase 7 but with equally potent antimicrobial activity. Our studies suggest RNase 6 serves as an evolutionarily conserved antimicrobial peptide that participates in the maintenance of urinary tract sterility.

11 June 2019 in Current Treatment Options in Pediatrics
Verified
Journal Article
Closed access
PDF file
ESEmily Stonebrook
Emily Stonebrook
MHMonica Hoff
Monica Hoff
JSJohn Spencer
John Spencer